BCA
MDT icon

Bray Capital Advisors’s Medtronic MDT Stock Holding History

Bray Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$475K Sell
5,949
-1,815
-23% -$157K 0.13% 101
2024
Q3 		$699K Sell
7,764
-530
-6% -$44.6K 0.17% 89
2024
Q2 		$653K Sell
8,294
-103
-1% -$8.44K 0.16% 90
2024
Q1 		$732K Sell
8,397
-395
-4% -$33.7K 0.19% 92
2023
Q4 		$724K Sell
8,792
-10,661
-55% -$813K 0.2% 91
2023
Q3 		$1.52M Sell
19,453
-425
-2% -$35.6K 0.46% 55
2023
Q2 		$1.75M Sell
19,878
-4,205
-17% -$362K 0.53% 51
2023
Q1 		$1.94M Sell
24,083
-2,619
-10% -$213K 0.57% 52
2022
Q4 		$2.08M Sell
26,702
-8,433
-24% -$683K 0.64% 45
2022
Q3 		$2.84M Sell
35,135
-19
-0.1% -$1.71K 0.89% 37
2022
Q2 		$3.15M Buy
35,154
+65
+0.2% +$6.59K 0.94% 34
2022
Q1 		$3.89M Buy
35,089
+1,276
+4% +$135K 1% 30
2021
Q4 		$3.5M Buy
33,813
+2,455
+8% +$284K 0.86% 36
2021
Q3 		$3.93M Buy
31,358
+278
+0.9% +$36K 1.01% 29
2021
Q2 		$3.86M Buy
31,080
+585
+2% +$73.5K 0.99% 31
2021
Q1 		$3.6M Buy
30,495
+129
+0.4% +$15.1K 0.99% 30
2020
Q4 		$3.56M Buy
30,366
+935
+3% +$103K 1.03% 30
2020
Q3 		$3.06M Buy
29,431
+365
+1% +$36.7K 1.08% 29
2020
Q2 		$2.67M Sell
29,066
-5,679
-16% -$545K 1.03% 31
2020
Q1 		$3.13M Sell
34,745
-1,010
-3% -$107K 1.44% 20
2019
Q4 		$4.06M Buy
35,755
+21
+0.1% +$2.3K 1.44% 19
2019
Q3 		$3.88M Sell
35,734
-205
-0.6% -$21.4K 1.52% 17
2019
Q2 		$3.5M Buy
35,939
+5,198
+17% +$475K 1.35% 23
2019
Q1 		$2.8M Buy
30,741
+2,406
+8% +$215K 1.16% 24
2018
Q4 		$2.58M Buy
28,335
+3,385
+14% +$316K 1.29% 24
2018
Q3 		$2.45M Buy
24,950
+395
+2% +$36.5K 1.08% 32
2018
Q2 		$2.1M Buy
24,555
+6,702
+38% +$560K 0.98% 33
2018
Q1 		$1.43M Buy
+17,853
New +$1.47M 0.67% 47
2015
Q3 		– Sell
-410
Closed -$30K – 414
2015
Q2 		$30K Buy
+410
New +$31.3K 0.02% 253

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bray Capital Advisors's MDT Position: Q4 2024 in Review

Bray Capital Advisors reduced its Medtronic (MDT) stake by 23% in Q4 2024, selling an estimated $157K and leaving 5,949 shares worth $475K. The position accounts for 0.13% of the portfolio, ranked #101.

Bray Capital Advisors first reported a position in MDT in Q2 2015 and has held it in 29 quarters since. The position peaked at $4.06M in Q4 2019. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Bray Capital Advisors held 5,949 shares of Medtronic worth $475K as of Q4 2024.
  • Bray Capital Advisors sold 1,815 Medtronic shares in Q4 2024, an estimated $157K.
  • Medtronic made up 0.13% of Bray Capital Advisors's portfolio in Q4 2024, its #101 holding.
  • Bray Capital Advisors first reported a position in Medtronic in Q2 2015 and has held it in 29 quarters since.
  • Bray Capital Advisors's Medtronic position peaked at $4.06M in Q4 2019.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.